568 related articles for article (PubMed ID: 33878734)
1. Identification of prognostic biomarkers associated with the occurrence of portal vein tumor thrombus in hepatocellular carcinoma.
Lin T; Lin Z; Mai P; Zhang E; Peng L
Aging (Albany NY); 2021 Apr; 13(8):11786-11807. PubMed ID: 33878734
[TBL] [Abstract][Full Text] [Related]
2. The impact of sphingosine kinase 1 on the prognosis of hepatocellular carcinoma patients with portal vein tumor thrombus.
Shi J; He YY; Sun JX; Guo WX; Li N; Xue J; Cheng SQ
Ann Hepatol; 2015; 14(2):198-206. PubMed ID: 25671829
[TBL] [Abstract][Full Text] [Related]
3. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
[TBL] [Abstract][Full Text] [Related]
4. Comparative transcriptome analysis reveals that the extracellular matrix receptor interaction contributes to the venous metastases of hepatocellular carcinoma.
Zhang H; Ye J; Weng X; Liu F; He L; Zhou D; Liu Y
Cancer Genet; 2015 Oct; 208(10):482-91. PubMed ID: 26271415
[TBL] [Abstract][Full Text] [Related]
5. Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition.
Cheng S; Chen M; Cai J;
Oncotarget; 2017 Jan; 8(5):8867-8876. PubMed ID: 27780939
[TBL] [Abstract][Full Text] [Related]
6. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.
Liu S; Tang Q; Huang J; Zhan M; Zhao W; Yang X; Li Y; Qiu L; Zhang F; Lu L; He X
Aging (Albany NY); 2021 Apr; 13(8):11257-11280. PubMed ID: 33820866
[TBL] [Abstract][Full Text] [Related]
7. Progress on the molecular mechanism of portal vein tumor thrombosis formation in hepatocellular carcinoma.
Zhang M; Ding Q; Bian C; Su J; Xin Y; Jiang X
Exp Cell Res; 2023 May; 426(1):113563. PubMed ID: 36944406
[TBL] [Abstract][Full Text] [Related]
8. miR-517b-3p promotes the progression of portal vein tumor thrombus via activating Wnt/β-catenin signaling pathway in hepatocellular carcinoma.
Ke RS; Huang KZ; Bao DS; Yang JR; Wang HX; Lv LZ; Jiang Y; Liu ZH; Zhang FX
Mol Biol Rep; 2022 Aug; 49(8):7793-7805. PubMed ID: 35666423
[TBL] [Abstract][Full Text] [Related]
9. Risk factors of microvascular invasion, portal vein tumor thrombosis and poor post-resectional survival in HBV-related hepatocellular carcinoma.
Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
Hepatogastroenterology; 2014 Sep; 61(134):1696-703. PubMed ID: 25436365
[TBL] [Abstract][Full Text] [Related]
10. A Machine Learning Approach Yields a Multiparameter Prognostic Marker in Liver Cancer.
Liu X; Lu J; Zhang G; Han J; Zhou W; Chen H; Zhang H; Yang Z
Cancer Immunol Res; 2021 Mar; 9(3):337-347. PubMed ID: 33431375
[TBL] [Abstract][Full Text] [Related]
11. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z
Front Immunol; 2021; 12():653836. PubMed ID: 33897701
[No Abstract] [Full Text] [Related]
12. Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion.
Spreafico C; Sposito C; Vaiani M; Cascella T; Bhoori S; Morosi C; Lanocita R; Romito R; Chiesa C; Maccauro M; Marchianò A; Mazzaferro V
J Hepatol; 2018 Apr; 68(4):724-732. PubMed ID: 29331342
[TBL] [Abstract][Full Text] [Related]
13. Identification of two portal vein tumor thrombosis associated proteins in hepatocellular carcinoma: protein disulfide-isomerase A6 and apolipoprotein A-I.
Xu X; Wei X; Ling Q; Cheng J; Zhou B; Xie H; Zhou L; Zheng S
J Gastroenterol Hepatol; 2011 Dec; 26(12):1787-94. PubMed ID: 21649721
[TBL] [Abstract][Full Text] [Related]
14. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
[TBL] [Abstract][Full Text] [Related]
15. Foxp3+ regulatory T cells and the formation of portal vein tumour thrombus in patients with hepatocellular carcinoma.
Shen SL; Liang LJ; Peng BG; He Q; Kuang M; Lai JM
Can J Surg; 2011 Apr; 54(2):89-94. PubMed ID: 21251418
[TBL] [Abstract][Full Text] [Related]
16. A new classification for hepatocellular carcinoma with portal vein tumor thrombus.
Shi J; Lai EC; Li N; Guo WX; Xue J; Lau WY; Wu MC; Cheng SQ
J Hepatobiliary Pancreat Sci; 2011 Jan; 18(1):74-80. PubMed ID: 20686792
[TBL] [Abstract][Full Text] [Related]
17. Screening potential prognostic biomarkers for portal vein emboli in patients with hepatocellular carcinoma.
Zhou W; Fang DL; He Y
J Gastrointest Oncol; 2021 Aug; 12(4):1927-1938. PubMed ID: 34532139
[TBL] [Abstract][Full Text] [Related]
18. Low expression of PAI-2 as a novel marker of portal vein tumor thrombosis and poor prognosis in hepatocellular carcinoma.
Zhou L; Jin Y; Cui QC; Jin KM; Zhou WX; Xing BC
World J Surg; 2013 Mar; 37(3):608-13. PubMed ID: 23188538
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
Tian Z; Wang Z; Chen Y; Qu S; Liu C; Chen F; Ma L; Zhu J
Med Sci Monit; 2020 Mar; 26():e922159. PubMed ID: 32231177
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma.
Liu S; Guo W; Shi J; Li N; Yu X; Xue J; Fu X; Chu K; Lu C; Zhao J; Xie D; Wu M; Cheng S; Liu S
J Hepatol; 2012 Feb; 56(2):389-96. PubMed ID: 21888875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
